Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:GRO

Agria Co. American Depo (GRO) Stock Price, News & Analysis

About Agria Co. American Depo Stock (NYSE:GRO)

Advanced Chart

Key Stats

Today's Range
$1.53
$1.74
50-Day Range
N/A
52-Week Range
$0.71
$1.66
Volume
531,887 shs
Average Volume
36,354 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50
Consensus Rating
Strong Buy

Company Overview

Receive GRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agria Co. American Depo and its competitors with MarketBeat's FREE daily newsletter.

GRO Stock News Headlines

This New Rule Could Change Everything
A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.
See More Headlines

GRO Stock Analysis - Frequently Asked Questions

Agria Co. American Depo (GRO) raised $71 million in an IPO on Tuesday, November 26th 2024. The company issued 4,300,000 shares at $15.00-$18.00 per share. Cantor, Bradesco BBI, Freedom Capital Markets and Roth Capital Partners served as the underwriters for the IPO and Clarksons Securities was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Agria Co. American Depo investors own include Allena Pharmaceuticals (ALNA), Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Ampio Pharmaceuticals (AMPE), Amarin (AMRN), Ampliphi Biosciences (APHB) and ArQule (ARQL).

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NYSE:GRO
CIK
1413257
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$5.50
Low Price Target
$5.50
Potential Upside/Downside
+219.8%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:GRO) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners